OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Navigating the Management of Hepatocellular Carcinoma	396
Forthcoming Issues	63
Forthcoming Issues	44
Copyright	39
Special Population	36
Recurrent and De Novo Liver Disease After Liver Transplantation	35
The Role of Liver Transplantation in Hepatocellular Carcinoma	34
Forthcoming Issues	34
Contributors	29
Forthcoming Issues	28
Artificial Intelligence and Machine Learning Applications in Liver Disease	27
Contents	26
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	26
Preface	22
Overview of New Targets for Hepatitis B Virus	22
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	21
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	20
Pathogenesis of Alcohol-Associated Liver Disease	20
What is the Path Forward to Treat Hepatitis Delta Virus?	20
Preface	19
Consultations in Liver Disease	18
Nonalcoholic Fatty Liver Disease in Latin America and Australia	18
Primary Biliary Cholangitis	17
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	17
The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients	17

Portal Hypertension and its Complications	16
Alcohol-Associated Liver Disease	16
Contributors	16
Recent Advances in Primary Biliary Cholangitis Treatment	15
Biliary Atresia in Children	14
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	14
Copyright	13
Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Extrahepatic Cancers and Sarcopenia	13
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	13
Primary Sclerosing Cholangitis	13
Minimal Hepatic Encephalopathy	13
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	13
Current and Next-Generation Therapeutics in Hepatology	12
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	12
Prognostic Scoring Systems in Primary Biliary Cholangitis	12
Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America	12
Copyright	11
The Liver in Hematologic Malignancies	11
Hepatorenal Syndrome	11
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	10
Pharmacologic Management of Hepatic Encephalopathy	10
Hepatocellular Carcinoma	10
Beyond the Liver	10
The Liver in Diabetes and Metabolic Syndrome	10
Treatment of Primary Sclerosing Cholangitis Including Transplantation	9
Acute Alcoholic Hepatitis	9
Navigating Hepatocellular Carcinoma	9
Novel Therapies in Primary Biliary Cholangitis	9
Copyright	9
Treatment of Modifiable Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease	9
Overview of Progressive Familial Intrahepatic Cholestasis	9
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease	9
Hepatitis B and C in Children	9
Contents	9
Alcohol Use Disorder	9
Hepatic Encephalopathy	8
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	8
Preventing Readmissions for Hepatic Encephalopathy	8
Disparities in Alcohol-Related Liver Disease	8
Forthcoming Issues	8
State of the Art	8
Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean	8
Primary Biliary Cholangitis	8
Amyloidosis and the Liver	8
Renal Insufficiency in Patients with Cirrhosis	8
Kidney Allocation Issues in Liver Transplantation Candidates with Chronic Kidney Disease and Severe Kidney Liver Injury	8
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	8
Genetics of Primary Biliary Cholangitis	8
Chronic Hepatitis B	8
Alcohol-Related Liver Disease	8

Contents	8
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	8
Disease Modulating Agents in Cirrhosis	8
Alagille Syndrome	7
Hepatic Encephalopathy in Acute-on-Chronic Liver Failure	7
Metabolic Dysfunction–Associated Steatotic Liver Disease	7
Chronic Hepatitis B Virus and Hepatitis D Virus	7
Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis	7
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis	7
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease	7
Contributors	7
Autoimmune Hepatitis	7
Systemic Complications of Primary Biliary Cholangitis	7